• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Advent Technologies Reports Q4 2023 Results

    8/20/24 7:00:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ADN alert in real time by email

    Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent" or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology space, announced on Tuesday, August 13, 2024 its consolidated financial results for the three months and year ended December 31, 2023. All amounts are in U.S. dollars unless otherwise noted and have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP").

    Q4 2023 Financial Highlights

    (All comparisons are to Q4 2022, unless otherwise stated)

    • Revenue of $1.5 million and income from grants of $0.8 million, totaling $2.3 million, which represents a decrease of (3.6)% year-over-year.
    • Full year 2023 revenue of $4.9 million and income from grants of $2.5 million, totaling $7.4 million. This represents a decrease of (20.9)% year-over-year.
    • Operating expenses of $44.6 million, representing a year-over-year decrease of $1.1 million.
    • Net loss in Q4 of $(25.7) million or $(12.04) per share, and adjusted net loss of $(22.1) million or $(10.32) per share. Adjusted net loss excludes a $0.03 million gain from the change in the fair value of outstanding warrants, and a $3.71 million goodwill and intangible asset impairment charge.
    • Unrestricted cash reserves were $3.6 million as of December 31, 2023, a decrease of $0.1 million from September 30, 2023.

    "Our product development efforts center around a common core technology: a fuel cell and MEA (membrane electrode assembly) designed to address heavy-duty automotive applications and large-scale stationary systems. Success with our MEA technology is key to unlocking these markets with the right OEM partnerships," said Dr. Vasilis Gregoriou, Advent's Chairman and CEO. "Our recent restructuring initiatives have been pivotal in significantly reducing costs. We have already achieved a 70% cost reduction compared to the same time last year. As a result of our strategic shift and a reduction in direct sales efforts, particularly in remote regions, we experienced a decrease in revenue in 2023, which we view as a temporary adjustment. We believe it is prudent to demonstrate this short-term revenue reduction rather than overextend our financial resources. Our goal is to operate as close as possible to break-even relying on the strategic OEM partnership funds and R&D government funds and to have the maximum runway until the inflection point. The partnering OEMs plans for mass production will determine the inflection point timing. We appreciate your ongoing support and patience and look forward to updating you on our progress."

    Company Updates

    Technology Update

    The Advent Fuel Cell platform, based on our new Ion Pair™ Membrane Electrode Assembly (MEA), offers superior heat management and the ability to operate with liquid eFuels and biofuels. These unique properties, combined with the MEA's increased power density, form the basis for breakthrough innovation in the fuel cell industry. Our partnerships with industry leaders such as Airbus, the US Army, Hyundai Motor Company, and Siemens Energy not only validate our technological achievements but also highlight the potential of our technology. Our HT-PEM fuel cell technology is ideal for marine and off-grid power applications, both of which are increasingly adopting methanol. Additionally, our high-temperature operation results in superior efficiency, reaching up to 85% when heat is utilized. This positions HT-PEM as optimal for a wide range of applications, including aviation and heavy-duty trucks. The Ion Pair MEA technology has achieved in 2024 approximately double the power of previous state of the art fuel cells per cm². We also have concrete data that we will achieve double the lifetime of competing HT-PEM fuel cell systems. Our fuel cells convert approximately 400 grams of methanol into 1kWh of electrical power, (equivalent to a battery with a power density of 2,500 Wh/kg)—exceeding by a factor of 10 the power density of lithium-ion batteries. Moreover, unlike batteries or hydrogen-based systems, our fuel cells utilize the existing global infrastructure for transporting and dispensing liquid fuels. This advantage is especially beneficial for developing regions. The Ion Pair MEA technology overcomes the prior limitations of the HT-PEM technology.

    Operations Update

    In the past year, our journey has been marked by a blend of both encouraging and challenging developments. On a positive note, there has been an unprecedented surge in interest across various markets for methanol fuel cells and clean power solutions. However, the financial landscape for clean energy investments has been less favorable, pushing us to seek support through EU infrastructure loans and grants and a private loan from a US-based institutional investor. These processes are typically accompanied by extended bureaucratic processes. Over the years, particularly after our acquisition of Serenergy (Denmark), we have advanced our hardware technology, selling 1,200 systems mainly to the telecom industry. This expertise provides a solid foundation for accelerating partnerships through technology transfer and licensing. However, we have chosen not to remain an end-product OEM across multiple markets, as achieving this would require very significant investment and considerable time. As a result, we have discontinued operations of certain subsidiaries that focused on end-system production, which demanded increasing capital for low-margin or negative-margin revenues.

    We have closed non-profitable subsidiaries and facilities in Boston and Denmark, and the Philippines. The Danish subsidiary, in particular, was producing fuel cells with older HT-PEM technology at a cost exceeding $2,000 per kW. In contrast, with our Ion Pair MEA technology, we anticipate that OEMs can develop systems at a cost approaching $500 per kW at scale. Advent is now focusing on advancing MEA innovation, expanding intellectual property footprint, and scaling manufacturing in the future primarily through technology licensing and Joint Development Agreements. This strategic pivot enables us to reduce capital expenditures while maintaining high margins and a sustainable business model.

    Business Update

    Our new approach involves forming joint ventures and technology transfer agreements with major local integrators, Tier 1 suppliers, and OEMs. By focusing on manufacturing the MEA and potentially the fuel cell stack, we are establishing a scalable, low-capex, and high-margin operational framework.

    Global Market Expansion and Partnerships

    1. Automotive

    In the automotive industry, our MEA technology is currently evaluated by four of the top ten global automakers. In addition, our collaboration with Hyundai Motors has progressed to a Joint Development Agreement, and we aim to secure similar agreements with other major automakers by the end of 2024. Our high-temperature fuel cells offer exceptional benefits for trucks and heavy-duty vehicles, particularly in regions with extreme heat.

    2. Aerospace

    In aerospace, we have established a $13-million strategic partnership with Airbus to develop our Ion Pair MEA for aviation applications. This two-year Joint Development Agreement is designed to meet aviation performance standards, paving the way for test flights and hardware systems in the near future, with the ultimate goal of enabling fuel cell-powered aircraft.

    3. Defense

    In the defense sector, we signed in September and December 2023 two contracts (representing total value to the Company of $5 million), with the U.S. Department of Defense. These contracts refer to the HB50 product, a human-portable fuel cell that delivers power for military missions. We are integrating our Ion Pair MEA technology to enhance the HB50's performance and scale up production by 2026. The objective is to facilitate the shift from low-prototype volume to manufacturing-scale volume. The program is advancing steadily, with daily collaboration with the U.S. Department of Defense. Significant milestones to date have been successfully achieved.

    4. Marine

    Our technology is already deployed in Sanlorenzo's 50Steel methanol fuel cell superyacht, Almax. We believe methanol, including biomethanol and e-methanol, is crucial for decarbonizing the marine industry. With over 130 methanol projects globally, we anticipate significant adoption in both retrofitted and new yachts.

    5. Data Centers

    We are also pursuing collaborations with OEMs in the data center off-grid power market, where we believe our fuel cell technology presents distinct advantages. Data centers currently account for 1-2% of global power usage, a figure expected to rise to 3-4% by 2030 (1000TWhs per year). We anticipate that this increase will drive substantial growth in electricity demand, particularly in the US and Europe, and could double carbon emissions from data centers by 2030.

    We believe that our fuel cells can reduce capex and accelerate deployment by eliminating the need for grid upgrades and extensive permits. Our technology's multifuel capability allows for immediate deployment with methanol (on green eMethanol), biogas and the option to switch to hydrogen or other fuels We are actively engaging with companies interested in leveraging our HT-PEM technology for large-scale data center projects.

    R&D Programs

    Our teams are actively engaged in a comprehensive portfolio of 13 research and development programs, with total funding amounting to approximately $10 million. These programs receive support from notable sources, including the European Union and key European institutions such as Horizon Europe and the Clean Hydrogen Partnership. In addition to these ongoing initiatives, we are also forming strategic partnerships and submitting proposals for new programs with substantial funding opportunities, such as the European Innovation Fund. These efforts are designed to further advance our technology and expand our collaborative network with leading industry partners. This extensive network not only enhances our technological capabilities but also ensures that we remain at the forefront of innovation in our field.

    Conference Call

    The Company will host a conference call on Tuesday, August 20, 2024, at 9:00 AM ET to discuss its results. To access the call please dial (800) 715-9871 from the United States, or +1 (646) 307-1963 from outside the U.S. The conference call I.D. number is 9909908. Participants should dial in 5 to 10 minutes before the scheduled time. Participants can also attend the call virtually by visiting the homepage of Advent's Investor Relations (IR) website, where they can register for the event under the "Latest Events" section.

    A replay of the call can also be accessed via phone through September 3, 2024, by dialing (800) 770-2030 from the U.S., or +1(609) 800-9909 from outside the U.S. The conference I.D. number is 9909908. An archived version will be available after the event on the homepage of Advent's Investor Relations (IR) website, under the "Latest Events" section.

    About Advent Technologies Holdings, Inc

    Advent Technologies Holdings, Inc. is a U.S. corporation that develops, manufactures, and assembles complete fuel cell systems as well as supplying customers with critical components for fuel cells in the renewable energy sector. Advent is headquartered in California and holds the IP for next-generation HT-PEM that enables various fuels to function at high temperatures and under extreme conditions, suitable for the automotive, aviation, defense, oil and gas, marine, and power generation sectors. For more information, visit www.advent.energy.

    Cautionary Note Regarding Forward-Looking Statements

    This press release includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the Company's ability to maintain the listing of the Company's common stock on Nasdaq; future financial performance; public securities' potential liquidity and trading; impact from the outcome of any known and unknown litigation; ability to forecast and maintain an adequate rate of revenue growth and appropriately plan its expenses; expectations regarding future expenditures; future mix of revenue and effect on gross margins; attraction and retention of qualified directors, officers, employees and key personnel; ability to compete effectively in a competitive industry; ability to protect and enhance Advent's corporate reputation and brand; expectations concerning its relationships and actions with technology partners and other third parties; impact from future regulatory, judicial and legislative changes to the industry; ability to locate and acquire complementary technologies or services and integrate those into the Company's business; future arrangements with, or investments in, other entities or associations; and intense competition and competitive pressure from other companies worldwide in the industries in which the Company will operate; and the risks identified under the heading "Risk Factors" in Advent's Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on August 13, 2024, as well as the other information filed with the SEC. Investors are cautioned not to place considerable reliance on the forward-looking statements contained in this press release. You are encouraged to read Advent's filings with the SEC, available at www.sec.gov , for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this document, and the Company undertakes no obligation to update or revise any of these statements. Advent's business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties.

    Presentation of Non-GAAP Financial Measures

    In addition to the results provided in accordance with U.S. GAAP throughout this press release, the Company has provided non-GAAP financial measures - Adjusted Net Income / (Loss) and Adjusted EBITDA - which present results on a basis adjusted for certain items. The Company uses these non-GAAP financial measures for business planning purposes and in measuring its performance relative to that of its competitors. The Company believes that these non-GAAP financial measures are useful financial metrics to assess its operating performance from period-to-period by excluding certain items that the Company believes are not representative of its core business. These non-GAAP financial measures are not intended to replace, and should not be considered superior to, the presentation of the Company's financial results in accordance with GAAP. The use of the terms Adjusted Net Income / (Loss) and Adjusted EBITDA may differ from similar measures reported by other companies and may not be comparable to other similarly titled measures. These measures are reconciled from the respective measures under GAAP in the appendix below.

    ADVENT TECHNOLOGIES HOLDINGS, INC.

    CONSOLIDATED BALANCE SHEETS

    (Amounts in USD thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

     

     

    December 31,

    2023

     

     

    December 31,

    2022

     

    ASSETS

     

     

     

     

     

     

     

     

    Current assets:

     

     

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    3,562

     

     

    $

    32,869

     

    Restricted cash, current

     

     

    100

     

     

     

    -

     

    Accounts receivable, net

     

     

    191

     

     

     

    979

     

    Contract assets

     

     

    21

     

     

     

    52

     

    Inventories

     

     

    2,707

     

     

     

    12,620

     

    Prepaid expenses and Other current assets

     

     

    2,254

     

     

     

    2,980

     

    Total current assets

     

     

    8,835

     

     

     

    49,500

     

    Non-current assets:

     

     

     

     

     

     

     

     

    Goodwill

     

     

    -

     

     

     

    5,742

     

    Intangibles, net

     

     

    79

     

     

     

    6,062

     

    Property and equipment, net

     

     

    21,549

     

     

     

    17,938

     

    Right-of-use assets

     

     

    3,216

     

     

     

    4,055

     

    Restricted cash, non-current

     

     

    750

     

     

     

    750

     

    Other non-current assets

     

     

    308

     

     

     

    5,221

     

    Available for sale financial asset

     

     

    -

     

     

     

    320

     

    Total non-current assets

     

     

    25,902

     

     

     

    40,088

     

    Total assets

     

    $

    34,737

     

     

    $

    89,588

     

     

     

     

     

     

     

     

     

     

    LIABILITIES AND STOCKHOLDERS' EQUITY

     

     

     

     

     

     

     

     

    Current liabilities:

     

     

     

     

     

     

     

     

    Trade and other payables

     

    $

    5,087

     

     

    $

    4,680

     

    Deferred income from grants, current

     

     

    530

     

     

     

    801

     

    Contract liabilities

     

     

    2,015

     

     

     

    1,019

     

    Other current liabilities

     

     

    1,916

     

     

     

    4,703

     

    Operating lease liabilities

     

     

    2,186

     

     

     

    2,280

     

    Income tax payable

     

     

    179

     

     

     

    183

     

    Total current liabilities

     

     

    11,913

     

     

     

    13,666

     

    Non-current liabilities:

     

     

     

     

     

     

     

     

    Warrant liability

     

     

    59

     

     

     

    998

     

    Long-term operating lease liabilities

     

     

    8,230

     

     

     

    9,802

     

    Defined benefit obligation

     

     

    83

     

     

     

    72

     

    Deferred income from grants, non-current

     

     

    320

     

     

     

    50

     

    Other long-term liabilities

     

     

    684

     

     

     

    852

     

    Total non-current liabilities

     

     

    9,376

     

     

     

    11,774

     

    Total liabilities

     

     

    21,289

     

     

     

    25,440

     

     

     

     

     

     

     

     

     

     

    Commitments and contingent liabilities

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Stockholders' equity

     

     

     

     

     

     

     

     

    Common stock ($0.0001 par value per share; Shares authorized: 110,000,000 at December 31, 2023 and December 31, 2022; Issued and outstanding: 2,580,159 and 1,723,924 at December 31, 2023 and December 31, 2022, respectively)

     

     

    8

     

     

     

    5

     

    Preferred stock ($0.0001 par value per share; Shares authorized: 1,000,000 at December 31, 2023 and December 31, 2022; nil 0 issued and outstanding at December 31, 2023 and December 31, 2022)

     

     

    -

     

     

     

    -

     

    Additional paid-in capital

     

     

    194,933

     

     

     

    174,509

     

    Accumulated other comprehensive loss

     

     

    (2,334

    )

     

     

    (2,604

    )

    Accumulated deficit

     

     

    (179,159

    )

     

     

    (107,762

    )

    Total stockholders' equity

     

     

    13,448

     

     

     

    64,148

     

    Total liabilities and stockholders' equity

     

    $

    34,737

     

     

    $

    89,588

     

     

    ADVENT TECHNOLOGIES HOLDINGS, INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS

    (Amounts in USD thousands, except share and per share amounts)

     

    Three months ended December 31,

    Years Ended December 31,

    (Unaudited)

    (Unaudited)

    2023

    2022

    2023

    2022

    Revenue, net

    $

    1,506

     

    $

    1,957

     

    $

    4,859

     

    $

    7,837

    Cost of revenues

    (12,442)

    (2,455)

    (18,287)

    (8,581)

    Gross profit / (loss)

     

    (10,936)

     

     

    (498)

     

     

    (13,428)

     

     

    (744)

    Income from grants

    814

    449

    2,504

    1,460

    Research and development expenses

     

    (3,957)

     

     

    (2,458)

     

     

    (12,112)

     

     

    (9,796)

    Administrative and selling expenses

    (6,732)

    (9,258)

    (32,468)

    (35,915)

    Sublease income

     

    139

     

     

    -

     

     

    543

     

     

    -

    Amortization of intangible assets

     

    (116)

     

     

    (651)

     

     

    (642)

     

     

    (2,764)

    Credit loss – customer contracts

     

    (1,207)

     

     

    (1,116)

     

     

    (1,270)

     

     

    (1,116)

    Gain from purchase price adjustment

     

    -

     

     

    2,370

     

     

    -

     

     

    2,370

    Impairment losses

     

    (3,705)

     

     

    (38,922)

     

     

    (13,468)

     

     

    (38,922)

    Operating loss

     

    (25,700)

     

    (50,084)

     

    (70,341)

     

    (85,427)

    Fair value change of warrant liability

     

    39

     

     

    2,127

     

     

    394

     

     

    9,375

    Finance income / (expenses), net

    (44)

    61

    74

    52

    Foreign exchange gains / (losses), net

     

    (9)

     

     

    (40)

     

     

    97

     

     

    (91)

    Other income / (expenses), net

    (19)

    4

    (902)

    (216)

    Loss before income tax

     

    (25,733)

     

     

    (47,932)

     

     

    (70,678)

     

     

    (76,307)

    Income taxes

    1

    307

    (719)

    1,970

    Net loss

    $

    (25,732)

     

    $

    (47,625)

     

    $

    (71,397)

     

    $

    (74,337)

    Net loss per share

    Basic loss per share

     

    (12.04)

     

     

    (27.63)

     

     

    (37.24)

     

     

    (43.28)

    Basic weighted average number of shares

    2,136,840

    1,723,924

    1,917,179

    1,717,623

    Diluted loss per share

     

    (12.04)

     

     

    (27.63)

     

     

    (37.24)

     

     

    (43.28)

    Diluted weighted average number of shares

    2,136,840

    1,723,924

    1,917,179

    1,717,623

     

    ADVENT TECHNOLOGIES HOLDINGS, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (Amounts in USD thousands)

     

    Years Ended December 31,

    (Unaudited)

    2023

    2022

    Net Cash used in Operating Activities

    $

    (32,115)

    $

    (32,125)

     

    Cash Flows from Investing Activities:

     

     

     

     

    Proceeds from sale of property and equipment

     

    256

     

    -

    Purchases of property and equipment

    (3,371)

    (11,527)

    Purchases of intangible assets

     

    -

     

    (117)

    Advances for the acquisition of property and equipment

    (1,255)

    (2,557)

    Acquisition of a subsidiary, net of cash acquired

     

    (1,864)

     

    -

    Acquisition of available for sale financial assets

    -

    (316)

    Net Cash used in Investing Activities

    $

    (6,234)

    $

    (14,517)

     

    Cash Flows from Financing Activities:

     

     

     

     

    Issuance of common stock and paid-in capital, net of issuance costs paid

    9,059

    -

    Repayments of debt

     

    -

     

    (40)

    Net Cash (used in) provided by Financing Activities

    $

    9,059

    $

    (40)

     

    Net (decrease) / increase in cash, cash equivalents, restricted cash and restricted cash equivalents

    $

    (29,290)

    $

    (46,682)

    Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents

    83

    537

    Cash, cash equivalents, restricted cash and restricted cash equivalents at the beginning of year

     

    33,619

     

    79,764

    Cash, cash equivalents, restricted cash and restricted cash equivalents at the end of year

    $

    4,412

    $

    33,619

    Supplemental Non-GAAP Measures and Reconciliations

    In addition to providing measures prepared in accordance with GAAP, we present certain supplemental non-GAAP measures. These measures are EBITDA, Adjusted EBITDA and Adjusted Net Income / (Loss), which we use to evaluate our operating performance, for business planning purposes and to measure our performance relative to that of our peers. These non-GAAP measures do not have any standardized meaning prescribed by GAAP and therefore may differ from similar measures presented by other companies and may not be comparable to other similarly titled measures. We believe these measures are useful in evaluating the operating performance of the Company's ongoing business. These measures should be considered in addition to, and not as a substitute for net income, operating expense and income, cash flows and other measures of financial performance and liquidity reported in accordance with GAAP. The calculation of these non-GAAP measures has been made on a consistent basis for all periods presented.

    EBITDA and Adjusted EBITDA

    These supplemental non-GAAP measures are provided to assist readers in determining our operating performance. We believe this measure is useful in assessing performance and highlighting trends on an overall basis. We also believe EBITDA and Adjusted EBITDA are frequently used by securities analysts and investors when comparing our results with those of other companies. EBITDA differs from the most comparable GAAP measure, net income / (loss), primarily because it does not include interest, income taxes, depreciation of property, plant and equipment, and amortization of intangible assets. Adjusted EBITDA adjusts EBITDA for one-time transaction costs, asset impairment charges, changes in warrant liability, and executive severance.

    The following tables show a reconciliation of net income / (loss) to EBITDA and Adjusted EBITDA for the three months and years ended December 31, 2023 and 2022.

     

    Three months ended December 31,

    Years Ended December 31,

    EBITDA and Adjusted EBITDA

    (Unaudited)

    (Unaudited)

    (in Millions of U.S. dollars)

     

    2023

    2022

    $ change

    2023

    2022

    $ change

    Net loss

    $

    (25.73)

     

    $

    (47.63)

    21.90

    $

    (71.40)

     

    $

    (74.34)

    2.94

    Depreciation of property and equipment

    $

    0.91

    $

    0.36

    0.55

    $

    3.01

    $

    1.49

    1.52

    Amortization of intangibles

    $

    0.11

     

    $

    0.65

    (0.54)

    $

    0.64

     

    $

    2.76

    (2.12)

    Finance income / (expenses), net

    $

    0.05

    $

    (0.06)

    0.11

    $

    (0.07)

    $

    (0.05)

    (0.02)

    Other income / (expenses), net

    $

    0.02

     

    $

    0.00

    0.02

    $

    0.90

     

    $

    0.22

    0.68

    Foreign exchange differences, net

    $

    0.01

    $

    0.04

    (0.03)

    $

    (0.10)

    $

    0.09

    (0.19)

    Income taxes

    $

    -

     

    $

    (0.31)

    0.31

    $

    0.72

     

    $

    (1.97)

    2.69

    EBITDA

    $

    (24.63)

     

    $

    (46.95)

    22.32

    $

    (66.30)

     

    $

    (71.80)

    5.50

    Net change in warrant liability

    $

    (0.03)

     

    $

    (2.13)

    2.10

    $

    (0.39)

     

    $

    (9.38)

    8.99

    Gain from purchase price adjustment

    $

    -

     

    $

    (2.37)

    2.37

    $

    -

     

    $

    (2.37)

    2.37

    Impairment loss – intangible assets and goodwill

    $

    3.71

     

    $

    38.92

    (35.21)

    $

    13.47

     

    $

    38.92

    (25.45)

    Adjusted EBITDA

    $

    (20.95)

     

    $

    (12.53)

    (8.42)

    $

    (53.22)

     

    $

    (44.63)

    (8.59)

    Adjusted Net Income / (Loss)

    This supplemental non-GAAP measure is provided to assist readers in determining our financial performance. We believe this measure is useful in assessing performance and highlighting trends on an overall basis. Adjusted Net Loss differs from the most comparable GAAP measure, net income / (loss), primarily because it does not include one-time transaction costs, asset impairment charges, changes in warrant liability, and executive severance. The following table shows a reconciliation of net income / (loss) for the three months and years ended December 31, 2023 and 2022.

    Three months ended December 31,

    Years Ended December 31,

    Adjusted Net Loss

    (Unaudited)

    (Unaudited)

    (in Millions of U.S. dollars)

    2023

    2022

    $ change

    2023

    2022

    $ change

    Net loss

    $

    (25.73)

    $

    (47.63)

    21.90

    $

    (71.40)

    $

    (74.34)

    2.94

    Net change in warrant liability

    $

    (0.03)

    $

    (2.13)

    2.10

    $

    (0.39)

    $

    (9.38)

    8.99

    Gain from purchase price adjustment

    $

    -

    $

    (2.37)

    2.37

    $

    -

    $

    (2.37)

    2.37

    Impairment loss – intangible assets and goodwill

    $

    3.71

    $

    38.92

    (35.21)

    $

    13.47

    $

    38.92

    (25.45)

    Adjusted Net Loss

    $

    (22.05)

    $

    (13.21)

    (8.84)

    $

    (58.32)

    $

    (47.17)

    (11.15)

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240820647258/en/

    Get the next $ADN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ADN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ADN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Advent Technologies Announces Bryan Holasek as Chief Strategy Officer

      LIVERMORE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology sector, is pleased to announce that Bryan Holasek has joined the Company as the Chief Strategy Officer. Mr. Holasek has over 42 years of experience in advancing technology from concept to product development. He was introduced to HT-PEM Fuel Cells through Trenergi Corp. He has founded several tech companies, including Revolutionary Integrations Group (AI and Machine Learning) and 369 Power and Energy Group (alternative energy systems). Previously, Mr. Holasek was Vice President of Corporate Dev

      5/7/25 8:00:00 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Holdings Receives Nasdaq Notice on Late Filing of its Form 10-K

      LIVERMORE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:ADN). Advent Technologies Holdings, Inc. announced today that, as expected, it received a notice from Nasdaq on April 16, 2025, notifying the Company that it is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because the Company's Annual Report on Form 10-K for the year ended December 31, 2024 ("Fiscal Year 2024 10-K") was not filed with the Securities and Exchange Commission (the "SEC") by the required due date of March 31, 2025. This Notice received from Nasdaq has no immediate effect on the listing or trading of the Company's shares. Nasdaq has pro

      4/16/25 8:00:25 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies receives Go-Ahead from Airbus for Phase Two of Joint Benchmarking Project

      LIVERMORE, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology space, is pleased to announce that it has received the go-ahead decision from Airbus, a leading aircraft manufacturer, to proceed with Phase Two of the parties' joint benchmarking project for an optimized Ion Pair™ Membrane Electrode Assembly ("MEA") for hydrogen fuel cells. Having demonstrated continued improvement in Ion Pair™ MEA performance in Phase One, the parties seek to further optimize performance in Phase Two. Advent has invested in people, materials, hardware, and 3rd party research centers, to contribute to

      3/26/25 8:00:00 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous

    $ADN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Advent Technologies downgraded by Goldman with a new price target

      Goldman downgraded Advent Technologies from Buy to Neutral and set a new price target of $20.00

      5/18/21 6:31:17 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Jefferies initiated coverage on Advent Technologies with a new price target

      Jefferies initiated coverage of Advent Technologies with a rating of Buy and set a new price target of $18.00

      3/19/21 8:01:58 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Credit Suisse reiterated coverage on Acadian Timber with a new price target

      Credit Suisse reiterated coverage of Acadian Timber with a rating of Underperform and set a new price target of $18.00 from $16.00 previously

      3/17/21 8:43:34 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous

    $ADN
    SEC Filings

    See more
    • Advent Technologies Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Filer)

      4/16/25 8:20:02 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Holdings Inc. filed SEC Form 8-K: Other Events

      8-K - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Filer)

      4/15/25 3:35:46 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form NT 10-K filed by Advent Technologies Holdings Inc.

      NT 10-K - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Filer)

      3/31/25 3:55:41 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous

    $ADN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Advent Technologies Holdings Inc. (Amendment)

      SC 13G/A - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

      2/12/24 4:09:47 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SC 13G/A filed by Advent Technologies Holdings Inc. (Amendment)

      SC 13G/A - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

      1/10/24 2:49:54 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SC 13G/A filed by Advent Technologies Holdings Inc. (Amendment)

      SC 13G/A - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

      10/3/23 9:43:40 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous

    $ADN
    Leadership Updates

    Live Leadership Updates

    See more
    • Advent Technologies Announces Management and Board Changes

      LIVERMORE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology space, is pleased to announce changes to its board and C-suite by removing Chairman and Chief Executive Officer, Vasilis Gregoriou and Chief Strategy Officer, Chris Kaskavelis. Gary Herman, an experienced turnaround executive has been appointed as Interim CEO. Mr. Herman stated, "The changes were long overdue. Advent has tremendous untapped potential. Its technology is unsurpassed and offers a ubiquitous clean energy solution across multiple industries including aviation, heavy automotive,

      10/30/24 6:10:38 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Receives Nasdaq Notification Regarding Compliance with Listing Requirements and Appoints Three New Directors

      Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology sectors, today announced that it has received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") confirming that the Company has rectified its previous deficiency related to the filing of its annual report on Form 10-K on August 13, 2024. The letter also informed Advent Technologies that it remains noncompliant with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Quarterly Reports on Form 10-Q for the periods ended March 31, 2024 (the "First Quarter 10-Q") and June 30, 2024 (the "Second Quarter 10-Q" and, together with t

      9/4/24 6:01:00 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Announces Appointment of Naiem Hussain as Chief Financial Officer

      Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology space, announced today the appointment of Naiem Hussain as its new Chief Financial Officer pending the completion of the company's hiring protocols. Formerly serving as Advent's Chief Investment Officer, Mr. Hussain brings extensive expertise in corporate finance, with a focus on IPOs, fundraisings, and mergers and acquisitions within the energy technology and fuel cell industries. Mr. Hussain is replacing Kevin Brackman, who resigned from his position on January 5, 2024. Mr. Hussain's professional journey commenced at ICI plc, where he played a pivotal role in investor re

      1/11/24 6:03:00 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous

    $ADN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Dhaliwal Avtar

      4 - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Issuer)

      4/2/25 2:16:33 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form 3 filed by new insider Dhaliwal Avtar

      3 - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Issuer)

      4/2/25 2:15:48 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form 3 filed by new insider Lukash Seth M

      3 - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Issuer)

      3/11/25 5:56:13 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous

    $ADN
    Financials

    Live finance-specific insights

    See more
    • Advent Technologies Reports Q4 2023 Results

      Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent" or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology space, announced on Tuesday, August 13, 2024 its consolidated financial results for the three months and year ended December 31, 2023. All amounts are in U.S. dollars unless otherwise noted and have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). Q4 2023 Financial Highlights (All comparisons are to Q4 2022, unless otherwise stated) Revenue of $1.5 million and income from grants of $0.8 million, totaling $2.3 million, which represents a decrease of (3.6)% year-over-year. Full year 2023 revenue of $

      8/20/24 7:00:00 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Announces Date for Fourth Quarter and Fiscal 2023 Earnings Call

      Company to Report Q4 2023 Results on August 20, 2024 Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology sectors, today announced that it will host a conference call on Tuesday, August 20, 2024 at 9:00 AM ET to discuss its fourth quarter and fiscal 2023 financial results. A press release containing these results will be issued before the call. To access the call please dial (800) 715-9871 from the United States, or +1 (646) 307-1963 from outside the U.S. The conference call I.D. number is 9909908. Participants should dial in 5 to 10 minutes before the scheduled time. Participants can also attend the call virtually by vi

      8/14/24 9:28:00 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Reports Q3 2023 Results

      Operational Highlights Signed a term sheet with Airbus to launch a Joint Project for the potential use of HT-PEM fuel cells in aviation. Signed new supply contract with the U.S. Department of Defense of $2.2 million for portable power systems. Received order from a prominent fuel cell integrator in the Asian market with initial value of $1.3 million. Unveiled Advent's range of Serene Power Systems at the 2023 Monaco Yacht Show. Continued discussions with the Greek State to finalize its procedures for state aid funding of Advent's Green HiPo project, following official ratification from the European Commission under the Important Projects of Common European Interest ("IPCEI")

      11/14/23 7:00:00 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous